Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision

April 18, 2023

Foodtech Patents: Who’s on the Board and What Moves are they Making?

March 29, 2023

Amgen v. Sanofi Case on Enablement of Antibody Genus Claims Will be Heard at the Supreme Court; Cert Denied in Juno v. Kite

November 7, 2022

Tysabri® (natalizumab) Litigation Begins

September 15, 2022

Purple Book Update – Regeneron’s EYLEA (aflibercept)

June 7, 2022

Will the Supreme Court Take the Bait? CVSG Issued and Other Updates in the Amgen v. Sanofi Case

May 3, 2022

Not Backing Down Now – Multiple Amicus Curiae Briefs Filed for Amgen v. Sanofi

January 14, 2022

Laying Down the [Trademark] Law – The USPTO Signals Stricter Enforcement to Come

December 21, 2021

A Potential Pivot in Patent Procedure – Will the Supreme Court Hear Amgen’s Challenge to the Standard of Review for Enablement?

December 17, 2021